文献速递鼻科

木糖醇与阿法链道酶对慢性鼻窦炎黏液的体外黏液溶解作用

The in vitro mucolytic effect of xylitol and dornase alfa on chronic rhinosinusitis mucus.
PubMed 文献 · Int Forum Allergy Rhinol · 2017-06-28

该体外研究评估了5%木糖醇和1 mg/mL阿法链道酶对30例慢性鼻窦炎(CRS)患者湿黏液及17例患者术后干黏液痂的黏液溶解效果。两种制剂在0.1 Hz频率下降低湿黏液黏弹性及在10和100 s⁻¹剪切率下降低黏度的效果均显著优于生理盐水对照,并显著降低黏液痂边缘清晰度。结论认为二者可能是有用的黏液溶解剂,但需体内研究进一步验证。

要点

  • 5%木糖醇和1 mg/mL阿法链道酶降低CRS湿黏液黏弹性与黏度的效果显著优于生理盐水。
  • 两种制剂均显著降低术后黏液痂的边缘清晰度,促进干痂溶解。
  • 研究为体外实验,作者指出需体内研究评估其治疗难治性CRS的潜力。

核心结论

  • 木糖醇和阿法链道酶可能是有用的黏液溶解剂,促进术后黏液痂分解并降低湿黏液的黏弹性和黏度。
  • 作者指出需进行体内研究以评估这些制剂治疗难治性CRS的潜力。

研究设计与样本

  • 体外研究:用平板流变仪测量30例CRS患者湿黏液的黏弹性和黏度。
  • 通过检查17例CRS患者术后干黏液痂样本的外周透明度、中心透明度和边缘清晰度来测量溶解情况。

主要发现

  • 在0.1 Hz频率下,木糖醇和阿法链道酶降低湿黏液黏弹性的效果显著优于生理盐水对照。
  • 在10和100 s⁻¹剪切率下,两种处理产生的黏度均显著低于生理盐水。
  • 木糖醇和阿法链道酶相对于生理盐水显著降低黏液痂边缘清晰度。

临床怎么用

  • 原文未报告临床实践推荐。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The overproduction and stagnation of purulent mucus impair mucociliary clearance and exacerbate the symptoms of chronic rhinosinusitis (CRS). There is a clinical need for effective topical mucolytic agents to facilitate removal of mucus and improve postoperative outcomes. METHODS: The effects of xylitol (5%) and dornase alfa (1 mg/mL) on mucus and mucus crusts were investigated. Viscoelasticity and viscosity of wet mucus derived from 30 CRS patients was measured with a plate rheometer. Postoperative dried mucus crust dissolution was measured by examining peripheral transparency, central transparency, and border definition of treated crust samples from 17 CRS patients. RESULTS: Xylitol and dornase alfa reduced wet mucus viscoelasticity at a frequency of 0.1 Hz significantly more than the saline control. Treatments also produced significantly lower viscosities than saline at a shear rate of 10 and 100 seconds-1 . Xylitol and dornase alfa significantly decreased mucus crust border definition relative to saline. CONCLUSION: Xylitol and dornase alfa may be efficacious mucolytics, encouraging the breakdown of postoperative mucus crusts and the reduction of viscoelasticity and viscosity of wet mucus. In vivo study is required to evaluate the potential of these agents in treating recalcitrant CRS.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Hardcastle T, Jain R, Radcliff F, et al. The in vitro mucolytic effect of xylitol and dornase alfa on chronic rhinosinusitis mucus. Int Forum Allergy Rhinol. 2017. PMID: 28658521. doi:10.1002/alr.21970

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。